Skip Navigation

News & Resources


Subscribe to NHLBI Press Releases
June 12, 2017

During Men’s Health Week, NHLBI scientists available to discuss research on men’s health

June 12-18 is National Men’s Health Week and experts from the National Heart, Lung, and Blood Institute (NHLBI) are available to discuss research findings related to some of the more serious medical challenges that disproportionately affect men—sleep apnea, excess belly fat, and high blood pressure. All are linked to an increased risk for heart disease. The good news is that men can take steps now to prevent these problems or detect and treat them early enough to act against heart disease.

May 22, 2017

COPD National Action Plan aims to reduce the burden of the third leading cause of death

The National Heart, Lung, and Blood Institute (NHLBI), along with federal and non-federal partners, today released the first-ever COPD National Action Plan, a detailed, patient-centered roadmap for addressing one of the most urgent health concerns facing Americans. The plan was released at the American Thoracic Society International Conference meeting this week in Washington, D.C. NHLBI is part of the National Institutes of Health.

Subscribe to NHLBI In The News
July 18, 2017 : JAMA

Moderate weight gain during adulthood is associated with a significantly increased risk of major chronic diseases—including diabetes and heart disease—as well as an increased risk of death, according to a new study involving more than 100,000 people.  The study emphasizes the importance of preventing weight gain during adulthood, the researchers say. Partly funded by NHLBI, the findings appear in the Journal of the American Medical Association (JAMA).

HealthDay: More evidence that midlife weight gain harms your health
Clinical Endocrinology News: Even a few middle age pounds are dangerous
MedPage Today: Adding pounds in adulthood ups major health risks
Medscape: Modest weight gain in young adulthood hikes chronic disease risk
Medical News Today: Weight gain in early adulthood linked to health risks later in life

July 11, 2017 : eLife

Researchers are reporting that galectin-3, a protein that promotes cancer cell growth and is used as a biomarker for heart failure, is linked to tumors associated with two rare genetic diseases.  They found that the protein is produced by tumor cells in tuberous sclerosis complex (TSC), a genetic disease that produces tumors in a variety of organs, and lymphangioleiomyomatosis (LAM), a lung disease that typically affects women. This biomarker could be useful for assessing the severity of these two diseases and for evaluating response to treatments, the researchers say. Their study, which was partly funded by NHLBI, appears in the journal eLife Study links heart failure biomarker to tumors observed in rare genetic diseases

Newswise: Heart Failure Biomarker Linked to Rare Genetic Tumor-Causing Diseases

September 27, 2017 to September 28, 2017
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodeling and inflammation, vascular remodeling and inflammation, and tissue engineering/genome editing/new technologies.
October 26, 2017 to October 27, 2017
Jamaica Pegasus Hotel, Jamaica West Indies
The 11th annual SCiF conference will be co-hosted by the National Heart, Lung, and Blood Institute and The University of West Indies.